Cargando…
Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence
Ductal carcinoma in situ (DCIS) of the breast constitutes about 10% of all diagnosed breast cancers and, despite surgical removal, it may recur, either as DCIS or invasive breast cancer. Nuclear grade and growth pattern according to Andersen et al as well as surgical margins are factors that have be...
Autores principales: | Jirström, K, Ringberg, A, Fernö, M, Anagnostaki, L, Landberg, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394433/ https://www.ncbi.nlm.nih.gov/pubmed/14612904 http://dx.doi.org/10.1038/sj.bjc.6601398 |
Ejemplares similares
-
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
por: Hedberg, Y, et al.
Publicado: (2003) -
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
por: Stendahl, M, et al.
Publicado: (2004) -
Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004) -
Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002) -
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
por: Boland, G P, et al.
Publicado: (2004)